Cargando…

Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 Subjects

Coronavirus Disease 2019 (COVID-19) is a global pandemic caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While detection of SARS-CoV-2 by polymerase chain reaction with reverse transcription (RT-PCR) is currently used to diagnose acute COVID-19 infection, serologica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huynh, Angela, Arnold, Donald M., Smith, James W., Moore, Jane C., Zhang, Ali, Chagla, Zain, Harvey, Bart J., Stacey, Hannah D., Ang, Jann C., Clare, Rumi, Ivetic, Nikola, Chetty, Vasudhevan T., Bowdish, Dawn M. E., Miller, Matthew S., Kelton, John G., Nazy, Ishac
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073159/ https://www.ncbi.nlm.nih.gov/pubmed/33923828 http://dx.doi.org/10.3390/v13040697

Ejemplares similares

Longitudinal Characteristics of Anti-Platelet Factor 4 Immunoglobulin G in Vaccine-Induced Immune Thrombotic Thrombocytopenia
por: Huynh, Angela, et al.
Publicado: (2022)

The clinical and laboratory diagnosis of vaccine-induced immune thrombotic thrombocytopenia
por: Bissola, Anna-Lise, et al.
Publicado: (2022)

Comparison of three dosing intervals for the primary vaccination of the SARS-CoV-2 mRNA Vaccine (BNT162b2) on magnitude, neutralization capacity and durability of the humoral immune response in health care workers: A prospective cohort study
por: Leong, Darryl P., et al.
Publicado: (2023)

SARS-CoV-2 spike-dependent platelet activation in COVID-19 vaccine-induced thrombocytopenia
por: Appelbaum, Jacob, et al.
Publicado: (2022)

Antibody Responses to Third-Dose mRNA Vaccines in Nursing Home and Assisted Living Residents
por: Zhang, Ali, et al.
Publicado: (2022)

Lessons from vaccine-induced immune thrombotic thrombocytopenia
por: Kelton, John Greenhow, et al.
Publicado: (2021)

Vaccine-induced immune thrombotic thrombocytopenia: Updates in pathobiology and diagnosis
por: Jevtic, Stefan D., et al.
Publicado: (2022)

Early Omicron infection is associated with increased reinfection risk in older adults in long-term care and retirement facilities
por: Breznik, Jessica A., et al.
Publicado: (2023)

Characteristics of VITT antibodies in patients vaccinated with Ad26.COV2.S
por: Huynh, Angela, et al.
Publicado: (2022)

Antibody Responses 3-5 Months Post-Vaccination with mRNA-1273 or BNT163b2 in Nursing Home Residents
por: Breznik, Jessica A., et al.
Publicado: (2021)

Platelet variability index: a measure of platelet count fluctuations in patients with immune thrombocytopenia
por: Li, Na, et al.
Publicado: (2021)

The COVID Complex: A Review of Platelet Activation and Immune Complexes in COVID-19
por: Jevtic, Stefan D., et al.
Publicado: (2022)

Treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT)
por: Gabarin, Nadia, et al.
Publicado: (2022)

Lasting Changes to Circulating Leukocytes in People with Mild SARS-CoV-2 Infections
por: Kennedy, Allison E., et al.
Publicado: (2021)

Combination of two complementary automated rapid assays for diagnosis of heparin‐induced thrombocytopenia (HIT)
por: Warkentin, Theodore E., et al.
Publicado: (2020)

Timeline of heparin‐induced thrombocytopenia seroconversion in serial plasma samples tested using an automated latex immunoturbidimetric assay
por: Warkentin, Theodore E., et al.
Publicado: (2019)

Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia
por: Bourguignon, Alex, et al.
Publicado: (2021)

Venous Thromboembolism and Mild Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
por: Gabarin, Nadia, et al.
Publicado: (2021)

A venomous visitor from the tropics
por: Chagla, Zain, et al.
Publicado: (2015)

Unique features of vaccine-induced immune thrombotic thrombocytopenia; a new anti-platelet factor 4 antibody-mediated disorder
por: Venier, Laura M., et al.
Publicado: (2022)

High‐dose IVIG plus cangrelor platelet “anesthesia” during urgent heparin‐CPB in a patient with recent SRA‐negative HIT‐thrombosis with persisting platelet‐activating antibodies
por: Koster, Andreas, et al.
Publicado: (2020)

5-Methyl-12-phenylsulfonyl-12H-naphtho[1,2-b]carbazole
por: Vasudhevan, S., et al.
Publicado: (2011)

Phosphatidylserine externalization and procoagulant activation of erythrocytes induced by Pseudomonas aeruginosa virulence factor pyocyanin
por: Qadri, Syed M., et al.
Publicado: (2016)

Tocilizumab versus the Covid19 tempest: All’s well that ends well or much ado about nothing?
por: Lee, Todd C., et al.
Publicado: (2021)

2-Bromo-4-chloro-6-(4-fluorophenyliminomethyl)phenol
por: Puthilibai, G., et al.
Publicado: (2008)

492. Canadian consensus of COVID-19 policy and management aspects
por: Tsang, Kara, et al.
Publicado: (2020)

Myeloid-derived suppressor cells, age and cancer
por: Bowdish, Dawn ME
Publicado: (2013)

Case Report of Necrotizing Fasciitis Associated with Streptococcus pneumoniae
por: Jiao, Lei, et al.
Publicado: (2016)

4-(4-Methoxyphenyl)naphtho[2,3-b]thiophene
por: Vasudhevan, S., et al.
Publicado: (2012)

Melioidosis in a returned traveller
por: Chagla, Zain, et al.
Publicado: (2014)

Assessment of the Burden of SARS-CoV-2 Variants of Concern Among Essential Workers in the Greater Toronto Area, Canada
por: Chagla, Zain, et al.
Publicado: (2021)

Comparing the usability of the World Health Organization’s conventional tuberculosis guidelines to the eTB recommendations map: A two-arm superiority randomised controlled trial
por: Matthews, Micayla, et al.
Publicado: (2022)

The efficacy and safety of hydroxychloroquine for COVID-19 prophylaxis: A systematic review and meta-analysis of randomized trials
por: Lewis, Kimberley, et al.
Publicado: (2021)

Overprescription of antibiotics for treating hospitalized COVID-19 patients: A systematic review & meta-analysis
por: Rabbi, Fazle, et al.
Publicado: (2023)

Immunosenescence and Novel Vaccination Strategies for the Elderly
por: Dorrington, Michael G., et al.
Publicado: (2013)

Loss of Microbial Topography Precedes Infection in Infants
por: Surette, Michael G., et al.
Publicado: (2019)

Estimating SARS-CoV-2 seroprevalence in long-term care: a window of opportunity
por: Verschoor, Chris P, et al.
Publicado: (2022)

Utility of asymptomatic inpatient testing for COVID-19 in a low-prevalence setting: A multicenter point-prevalence study
por: Bai, Anthony D., et al.
Publicado: (2020)

Host cytokine responses distinguish invasive from airway isolates of the Streptococcusmilleri/anginosis group
por: Kaiser, Julienne C, et al.
Publicado: (2014)

Tachycardia amongst subjects recovering from severe acute respiratory syndrome (SARS)
por: Lau, Suet-Ting, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_vleb26g8fkfuktqo2f03aqhota